Terms: = Lung cancer AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1
159 results:
1. Evaluation of the preoperative neutrophil-to-lymphocyte ratio as a predictor of the micropapillary component of stage IA lung adenocarcinoma.
Chen C; Chen ZJ; Li WJ; Deng T; Le HB; Zhang YK; Zhang BJ
J Int Med Res; 2024 Apr; 52(4):3000605241245016. PubMed ID: 38661098
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
[TBL] [Abstract] [Full Text] [Related]
3. Segmentation of patients with small cell lung cancer into responders and non-responders using the optimal cross-validation technique.
Majd E; Xing L; Zhang X
BMC Med Res Methodol; 2024 Apr; 24(1):83. PubMed ID: 38589775
[TBL] [Abstract] [Full Text] [Related]
4. High CASC expression predicts poor prognosis of lung cancer: A systematic review with meta-analysis.
Han H; Huang H; Chen AP; Tang Y; Huang X; Chen C
PLoS One; 2024; 19(4):e0292726. PubMed ID: 38573879
[TBL] [Abstract] [Full Text] [Related]
5. Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell lung cancer Brain Metastases.
Vaios EJ; Shenker RF; Hendrickson PG; Wan Z; Niedzwiecki D; Winter SF; Shih HA; Dietrich J; Wang C; Salama AKS; Clarke JM; Allen K; Sperduto P; Mullikin T; Kirkpatrick JP; Floyd SR; Reitman ZJ
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1507-1518. PubMed ID: 38097090
[TBL] [Abstract] [Full Text] [Related]
6. Value of human epididymis secretory protein 4 in differentiating malignant from benign pleural effusion: an analysis of two cohorts.
Yang Q; Niu Y; Wen JX; Yang DN; Han YL; Wen XH; Yan L; Huang JH; Chen H; Zheng WQ; Jiang TW; Hu ZD
Ther Adv Respir Dis; 2023; 17():17534666231216566. PubMed ID: 38084849
[TBL] [Abstract] [Full Text] [Related]
7. Eosinophil may be a predictor of immune-related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary study.
Tasaki Y; Sugiyama Y; Hamamoto S; Naiki T; Uemura T; Yokota K; Kawakita D; Nakamura M; Ogawa R; Shimura T; Mimura Y; Hotta Y; Odagiri K; Ito N; Iida M; Kimura Y; Komatsu H; Kataoka H; Takiguchi S; Morita A; Iwasaki S; Okuda K; Niimi A; Yasui T; Furukawa-Hibi Y
Cancer Med; 2023 Dec; 12(24):21666-21679. PubMed ID: 37986680
[TBL] [Abstract] [Full Text] [Related]
8. Prediction of subsolid pulmonary nodule growth rate using radiomics.
Ma ZJ; Ma ZX; Sun YL; Li C; Jin L; Gao P; Li C; Li M
BMC Med Imaging; 2023 Nov; 23(1):177. PubMed ID: 37936095
[TBL] [Abstract] [Full Text] [Related]
9. lung cancer Prediction Using Electronic Claims Records: A Transformer-Based Approach.
Chen HY; Wang HM; Lin CH; Yang R; Lee CC
IEEE J Biomed Health Inform; 2023 Dec; 27(12):6062-6073. PubMed ID: 37824311
[TBL] [Abstract] [Full Text] [Related]
10. Exploring the association between COVID-19 and male genital cancer risk in European population: evidence from mendelian randomization analysis.
Wang D; Ma Y; Yan L; Gan W; Han Y; Tan JS; Zhao W
BMC Genom Data; 2023 Sep; 24(1):56. PubMed ID: 37749495
[TBL] [Abstract] [Full Text] [Related]
11. Real-world utilization of immune checkpoint inhibitors in extensive stage small-cell lung cancer in community settings.
Zu K; Arunachalam A; Hohlbauch A; Silver M; Robert N
Immunotherapy; 2023 Nov; 15(16):1375-1387. PubMed ID: 37694560
[TBL] [Abstract] [Full Text] [Related]
12. Whole-tumor histogram analysis of multi-parametric MRI for differentiating brain metastases histological subtypes in lung cancers: relationship with the Ki-67 proliferation index.
Zhang B; Zhou F; Zhou Q; Xue C; Ke X; Zhang P; Han T; Deng L; Jing M; Zhou J
Neurosurg Rev; 2023 Sep; 46(1):218. PubMed ID: 37659040
[TBL] [Abstract] [Full Text] [Related]
13. Optimizing Longitudinal Tobacco Cessation Treatment in lung cancer Screening: A Sequential, Multiple Assignment, Randomized Trial.
Fu SS; Rothman AJ; Vock DM; Lindgren BR; Almirall D; Begnaud A; Melzer AC; Schertz KL; Branson M; Haynes D; Hammett P; Joseph AM
JAMA Netw Open; 2023 Aug; 6(8):e2329903. PubMed ID: 37615989
[TBL] [Abstract] [Full Text] [Related]
14. The International Association for the Study of lung cancer Pleural Mesothelioma Staging Project: Updated Modeling of Prognostic Factors in Pleural Mesothelioma.
Wolf AS; Rosenthal A; Giroux DJ; Nowak AK; Bille A; de Perrot M; Kindler HL; Rice D; Opitz I; Rusch VW; Pass HI; ;
J Thorac Oncol; 2023 Dec; 18(12):1689-1702. PubMed ID: 37567386
[TBL] [Abstract] [Full Text] [Related]
15. Intraoperative Versus Preoperative Diagnosis of lung cancer: Differences in Treatments and Patient Outcomes.
Mack SJ; Collins ML; Whitehorn GL; Till BM; Grenda TR; Evans NR; Okusanya OT
Clin Lung Cancer; 2023 Dec; 24(8):726-732. PubMed ID: 37479586
[TBL] [Abstract] [Full Text] [Related]
16. Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid Tumors.
Liu Y; Mullangi S; Debono D; Chen X; Pham T; Fisch MJ; Gordon AS; Hershman DL
JCO Oncol Pract; 2023 Sep; 19(9):731-740. PubMed ID: 37384847
[TBL] [Abstract] [Full Text] [Related]
17. [Global evaluation of the mortality and hospitalization in the Italian contaminated sites included in the SENTIERI project].
Fazzo L; Minichilli F; Manno V; Iavarone I; Benedetti M; Contiero P; Maraschini A; Minelli G; Pasetto R; Ricci P
Epidemiol Prev; 2023; 47(1-2 Suppl 1):366-374. PubMed ID: 36825379
[TBL] [Abstract] [Full Text] [Related]
18. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
[TBL] [Abstract] [Full Text] [Related]
19. Real-world evaluation of atezolizumab and etoposide-carboplatin as a first-line treatment for extensive-stage small cell lung cancer.
Kim SH; Jo EJ; Mok J; Lee K; Kim KU; Park HK; Lee MK; Eom JS; Kim MH
Korean J Intern Med; 2023 Mar; 38(2):218-225. PubMed ID: 36800677
[TBL] [Abstract] [Full Text] [Related]
20. lung cancer recovery focus post pandemic: an income-deprived area paradigm.
Jaitly J; Mavilakandy A; Naeem M; Reddy RV; Goodman L; Johnson N; Frost M; Tsaknis G
Clin Med (Lond); 2023 Jan; 23(1):38-44. PubMed ID: 36697004
[TBL] [Abstract] [Full Text] [Related]
[Next]
